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Methods: 41consecutive patients (38 men and 3 women; age 52 9 years) with anterior
STEMI were enrolled. All patients were randomized into two groups and underwent
primary PCI for anterior STEMI: stenting after manual thrombectomy (aspiration group,
n22) and stenting without manual thrombectomy (conventional group, n19). The
thermodilution-derived coronary flow reserve (CFR) and index of microcirculatory
resistance (IMR) were measured by using the pressure-temperature sensor-tipped coro-
nary wire at the left anterior descending artery (LAD) after primary PCI. Baseline
echocardiography was performed before discharge and follow-up echocardiography was
performed 6 months later.
Results: There was no significant difference in reperfusion time (onset to balloon time)
and CFR (2.01  1.1 vs. 2.08  1.1, p  0.831), baseline ejection fraction (EF, 44.5 
7.5% vs. 48.0 8.0%, p 0.15), baseline wall motion score index (WMSI, 1.52 0.32
vs. 1.46  0.31, p  0.59) between two groups. But, there was significant difference in
IMR (22.3 8.7 vs. 29.5 11.9, p 0.037), EF (follow up EF – baseline EF, 5.86
7.2 vs. 1.29 2.5, p 0.011), WMSI (baseline WMSI – follow up WMSI,0.199
0.242 vs. 0.003  0.075, p  0.001) between two groups.
Conclusions: Compared with conventional PCI, manual thrombectomy before stenting
for patients with anterior STEMI seems to preserve microvascular integrity. Manual
thrombectomy as an adjunctive method of primary PCI for acute anterior STEMI might
have beneficial efficacy on myocardial microcirculation.
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Background: Drug-eluting stents (DES) are used in ST-segment elevation myocardial
infarction (STEMI) patients with good safety and efficacy, even in complex patient
subsets. This study aimed to compare the in-hospital and 1-year outcomes of STEMI
patients with complex clinical and angiographic characteristics treated with 1st- versus
2nd-generation DES.
Methods: The study included 524 consecutive STEMI patients with1 of the following
characteristics: Ejection fraction (EF) 30%, chronic renal insufficiency (CRI), cardio-
genic shock, bifurcation, unprotected left main, totally occluded, ACC/AHA Type C,
bypass graft, in-stent restenosis, presence of thrombus, 1 lesion treated, and stent
implantation length 28 mm. Clinical outcomes of patients treated with 1st-generation
DES (Cypher/Taxus) (n452) were compared to those treated with 2nd-generation DES
(Promux/Xience) (n102).
Results: Baseline demographics were similar in patients treated with 1st- vs. 2nd-
generation DES. Mean age was 62.2  12.5 years; 65% males; mean EF was 42  13
%; and 13.1% had CRI. IABP use (14.2% overall), procedure time (50 51 min overall),
lesion locations, graft and in-stent restenosis lesions were also similar. 2nd-generation
DES were used more frequently in Type C lesions (56.8 vs. 27.4 %, p0.001) and distal
lesions (25.2 vs. 13.8 %, p0.001). The number of implanted DES was 1.5  0.8
overall. Angiographic success was similar at 99.4% overall. There was no difference in
composite major in-hospital complications. 1-year mortality, revascularization, and major
adverse cardiac event rates were similar in both groups.(Table)
1st
generation
DES
2nd
generation
DES
P value(n452) (n102)
In-hospital Death 4.2 (19) 1 (1) 0.146
In-hospital Q-wave MI 0.4 (2) 0 (0) 1
In-hospital Urgent CABG 0.4 (2) 4 (4) 0.012
In-hospital Stent thrombosis 0.4 (2) 0 (0) 1
Major in-hospital complications
(death/QWMI/CABG)
4.9 (22) 4.9 (5) 1
1-year Death 10.3 (46) 6.9 (7) 0.305
1-year Q-wave MI 0.2 (19) 1 (1) 0.339
1-year Target Lesion
Revascularization
5.2 (22) 4.1 (4) 0.8
1-year Target Vessel
Revascularization
9.2 (39) 8.2 (8) 0.747
1-year Stent thrombosis 0.9 (4) 0 (0) 1
1-year MACE (Death/QWMI/
TVR)
17.9 (81) 14.7 (15) 0.438
Conclusions: Despite the presence of higher lesion complexity, the use of 2nd-generation
DES in a STEMI population with complex clinical and angiographic characteristics
results in similarly low rates of in-hospital and 1-year outcomes when compared to
1st-generation DES.
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Background: Troponin elevation is a risk factor for mortality in pts with non
ST-segment elevation acute coronary syndromes (NSTEACS). However, prognostic
impact of non-obstructive coronary artery disease (CAD) in NSTEACS pts with troponin
elevation is unknown.
Methods: In the ACUITY trial, 3-vessel quantitative coronary angiography was
performed in a formal substudy of 6,921 pts with moderate and high-risk NSTEACS.
Patients with elevated admission troponin levels ( local upper limit of normal) were
stratified by the presence or absence of obstructive CAD (any lesion with diameter
stenosis (DS) 50%). Propensity-score matching was performed to adjust for baseline
characteristics.
Results: Of 2,442 patients with elevated troponins, 197 (8.8%) had non-obstructive
CAD. Maximum DS was 83.5%  17.5 vs. 24.1%  12.2 (p0.0001) in pts with vs.
without obstructive CAD. Propensity score matching yielded 117 patients with non-
obstructive CAD and 351 patients with obstructive CAD with no significant baseline
differences including renal function and diabetes. Overall 1-year mortality was signifi-
cantly higher in pts with non-obstructive CAD (5.2% vs 1.2%; HR [95%CI]  4.57
[1.29,16.21], p0.01), driven mainly by higher non-cardiac mortality (Table). Con-
versely, recurrent MI and unplanned revascularization rates were higher in patients with
obstructive CAD.
Non-
obstructive
CAD
(n117)
Obstructive
CAD
(n351)
Relative Risk
[95% CI] P-Value
1 Month Outcomes
Death 2.6% (3) 0.3% (1) 9.07 [0.94,87.15] 0.02
Cardiac death 0.9% (1) 0.3% (1) 3.02 [0.19,48.24] 0.41
Non-cardiac death 1.7% (2) 0.0% (0) N/A 0.01
Recurrent MI 0.9% (1) 6.3% (22) 0.13 [0.02,1.00] 0.02
Unplanned revascularization 0.0% (0) 3.7% (13) N/A 0.04
Major bleeding 5.2% (6) 6.0% (21) 0.86 [0.35,2.12] 0.74
CVA/TIA 0.0% (0) 0.3% (1) N/A 1.00
1-Year Outcomes
Death 5.2% (6) 1.2% (4) 4.57 [1.29,16.21] 0.01
Cardiac death 1.7% (2) 0.9% (3) 2.03 [0.34,12.16] 0.43
Non-cardiac death 3.5% (4) 0.3% (1) 12.20 [1.4,109.1] 0.004
Recurrent MI 3.6% (4) 9.0% (31) 0.38 [0.13,1.08] 0.058
Unplanned revascularization 0.0% (0) 9.2% (31) N/A 0.001
CVA/TIA 0.0% (0) 0.3% (1) N/A 1.00
Conclusions: Patients presenting with NSTEACS symptoms and elevated troponin
levels in whom obstructive CAD is absent, are at significantly higher risk of 1-year
all-cause and non-cardiac mortality than those with obstructive CAD, despite lower rates
of unplanned revascularization and subsequent MI. Troponin elevation in pts with
non-obstructive CAD may be an important risk factor for mortality, prompting a
comprehensive search for an alternative diagnosis.
TCT-473
Admission At Nights Or Weekends Has No Adverse Effect On Mortality For
ST Elevation Myocardial Infarction Patients Treated By Primary
Percutaneous Coronary Intervention: Single Center Study From A Large
Tertiary Cardiac Unit In United Kingdom
Refai Showkathali1, John Davies1, Paul Kelly1, Jeremy Sayer1, Rajesh Aggarwal1,
Gerald Clesham1
1The Essex Cardiothoracic Centre, Basildon, United Kingdom
Background: Mortality amongst emergency medical admissions has been reported to be
higher when patients are admitted to hospital at nights and weekends. We studied the
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